Who
Francesca Barone
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Candel Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 1
- Sells
- 7
- Bought
- $1,993
- Sold
- $1.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Feb 2022
- Last trade
- 29 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jun 2026filed 1 Jul 2026 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $236K23,447 at $10.06 | filing |
| 29 Jun 2026filed 1 Jul 2026 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $236K23,447 at $10.06 | filing |
| 26 Jan 2026filed 28 Jan 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,000 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,000 at $0.00 | filing |
| 25 Jun 2025filed 26 Jun 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code A | $20K4,282 at $4.67 | filing |
| 18 Mar 2025filed 20 Mar 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,000 at $0.00 | filing |
| 18 Mar 2025filed 20 Mar 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code M | $28K18,000 at $1.55 | filing |
| 18 Mar 2025filed 20 Mar 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $282K32,146 at $8.76 | filing |
| 12 Feb 2025filed 14 Feb 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $98K13,534 at $7.23 | filing |
| 8 Jan 2025filed 10 Jan 2025 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $112K13,673 at $8.22 | filing |
| 29 Nov 2024filed 3 Dec 2024 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $101K22,081 at $4.56 | filing |
| 17 Jul 2024filed 19 Jul 2024 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $91K14,051 at $6.47 | filing |
| 11 Jul 2024filed 15 Jul 2024 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Sold | $75K12,645 at $5.97 | filing |
| 28 Nov 2023filed 30 Nov 2023 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code F | $18K19,748 at $0.90 | filing |
| 26 Nov 2023filed 28 Nov 2023 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code A | —112,790 at $0.00 | filing |
| 28 Apr 2023filed 2 May 2023 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 8 Dec 2022filed 12 Dec 2022 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,9931,238 at $1.61 | filing |
| 28 Nov 2022filed 30 Nov 2022 | CADL Candel TherapeuticsBiotechnology | SEC FORM 4 Code A | —90,877 at $0.00 | filing |
| 28 Feb 2022filed 1 Mar 2022 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.